Programme Lead: Professor Angela Wood
The consortium is open to all researchers who sign up to our principles and ways of working. For enquiries or to join the consortium, contact us at bhfdsc@hdruk.ac.uk.
Update
New projects requesting access to data in the NHS England Secure Data Environment will no longer be accepted under our current data sharing agreement with NHS England.
Research aims and questions
CVD-COVID-UK/COVID-IMPACT has enabled research focused on three broad aims:
Aim 1
What are the effects of heart and circulatory diseases or other prior health conditions, their risk factors and medications on susceptibility and poor outcomes (including admission to hospital, requirement for intensive care and death) from COVID-19 disease?
Aim 2
What is the direct impact of COVID-19 on heart and circulatory disease complications or on other health complications, as well as on medium and longer-term heart and circulatory disease or other health condition risks?
Aim 3
What is the indirect impact of the COVID-19 pandemic and the government and NHS response to it on the presentation, diagnosis, management and outcomes of heart and circulatory diseases or other health conditions?
What we did
Enabled COVID-19 connected research through access to national datasets
- Faster access to anonymised, linked, whole-population health data across the four nations of the UK .
- Secure data environments in collaboration with national data custodians .
- Single project proposal form and streamlined review process.
Provided data curation and analysis support
- Development and maintenance of data curation and analysis tools.
- Curation and data science services:
- Guidance on feasibility, planning, and data access .
- Curation service providing partial or full data curation for a project.
- Full service covering both curation and analysis.
- Help to make code and phenotypes easily accessible and reusable for other researchers, via GitHub and the HDR UK Phenotype Library.
Supported patient and public involvement and engagement (PPIE) and communications
- Public contributors review and approve project proposals.
- Research is aligned with public and patient priorities.
- Support for clear and accessible communication of research findings.
Find out more about our PPIE service.
Projects
Active
Investigating the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 outcomes
Reference: CCU001
Project lead(s): Jonathan Sterne, University of Bristol
Start date:
Topic(s): Blood pressure, Hypertension, Treatments, Whole population
Active
SARS-CoV-2 infection and vaccination and the risk of vascular events
Reference: CCU002
Project lead(s): William Whiteley, University of Edinburgh
Start date:
Topic(s): COVID vaccination, Inequalities
Active
Direct and indirect effects of the COVID-19 pandemic in individuals with cardiovascular disease
Reference: CCU003
Project lead(s): Amitava Banerjee, UCL
Start date:
Topic(s): Healthcare delivery, Model, Prediction
Consortium principles, processes, and ways of working
Membership and ways of working
Join the consortium
Researchers interested in accessing and contributing to CVD-COVID-UK/COVID-IMPACT are welcome to join.
Researcher Guidelines
Acknowledgements and open science commitment
- All manuscripts/reports must be open access
- Publications should include: “On behalf of the CVD-COVID-UK/COVID-IMPACT Consortium”
- Correct acknowledgement of funders and data sources
Privacy and Data Protection
The CVD-COVID-UK / COVID-IMPACT Privacy Statement outlines:
- How data is collected, stored, and protected
- What types of data are accessed
- How data is used for research
View the Privacy Statement.